# GW Pharmaceuticals

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/gw-pharmaceuticals/

## Facts

| Field | Value |
| --- | --- |
| Country | GB |
| Description | British biopharmaceutical company |
| OpenAlex ID | https://openalex.org/F4320314782 |
| ROR ID | https://ror.org/01gtctx88 |
| Works | 904 |

## Funder papers

- [Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes](https://scholariq.org/papers/intensive-blood-glucose-control-and-vascular-outcomes-in-patients-with-type-2/)
- [Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder](https://scholariq.org/papers/cannabis-responsive-biomarkers-a-pharmacometabolomics-based-application-to/)
- [Cannabidiol blood metabolite levels after cannabidiol treatment are associated with broadband EEG changes and improvements in visuomotor and non-verbal cognitive abilities in boys with autism requiring higher levels of support](https://scholariq.org/papers/cannabidiol-blood-metabolite-levels-after-cannabidiol-treatment-are-associated-2/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.